Browsing Tag
Apnimed
2 posts
Sleep apnoea biotech Apnimed (APMD) climbs in Nasdaq debut after upsized offering
Apnimed raised $192M in an upsized Nasdaq IPO to fund oxnimbi's launch, with the FDA's February 28, 2027 decision on the first oral OSA pill now the pivot.
IHL-42X screening begins as Incannex Healthcare enters a faster-moving oral sleep apnea race
Incannex Healthcare begins IHL-42X screening as cash, buybacks and Apnimed’s FDA filing reshape the oral sleep apnea investment case.